Wildgen provides Biotech Venture Lounge winner with comprehensive package
SeaLife Pharma, an Austrian drug manufacturer, was named ‘Best start-up from the Biotech sector’ at the Biotech Venture Lounge and received a comprehensive package from Wildgen.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wildgen
Briefings from Wildgen
Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November 2014 regards key information documents for packaged retail and insurance-based investment products.
How funds can qualify as an ELTIF under new European Commission rules.